GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Basic Sciences/Mechanocrine signaling, Yap, HB-EGF, and liver regeneration.

Mechanocrine signaling, Yap, HB-EGF, and liver regeneration.

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated November 1, 2025

Quick Answer

Mechanocrine signaling, Yap (Yes-associated protein), HB-EGF (heparin-binding EGF-like growth factor), and liver regeneration are interconnected elements that play pivotal roles in the process of liver regrowth, particularly after partial hepatectomy (PHx). Below is a detailed explanation of their relationship and significance: ### **Mechanocrine Signaling in Liver Regeneration** Mechanocrine signaling refers to the process by which mechanical forces, such as shear stress and stretch, are converted into biochemical signals that drive...


Mechanocrine signaling, Yap (Yes-associated protein), HB-EGF (heparin-binding EGF-like growth factor), and liver regeneration are interconnected elements that play pivotal roles in the process of liver regrowth, particularly after partial hepatectomy (PHx). Below is a detailed explanation of their relationship and significance:

### **Mechanocrine Signaling in Liver Regeneration**

Mechanocrine signaling refers to the process by which mechanical forces, such as shear stress and stretch, are converted into biochemical signals that drive cellular responses. In the context of liver regeneration:

1. **Triggering Events:** After PHx, the liver experiences increased sinusoidal blood flow and shear stress due to the reduced liver mass. These mechanical forces act as stimuli that initiate molecular and cellular responses independent of traditional ligand-receptor signaling.

2. **Key Players:** Liver sinusoidal endothelial cells (LSECs) are particularly responsive to these mechanical forces. They sense the increased flow and stretch, triggering intracellular signaling cascades.

### **Role of Yap in Mechanocrine Signaling**

Yap is a transcriptional coactivator and a key mechanosensitive protein that translates mechanical signals into gene expression changes. Yap plays a critical role in liver regeneration by:

1. **Activation via Mechanical Stretch:** Increased sinusoidal flow activates integrin β1 on LSECs, leading to actin polymerization. This mechanical stretch facilitates Yap's migration into the nucleus.

2. **Nuclear Entry:** Actin polymerization opens nuclear pores, allowing Yap to enter the nucleus.

3. **Transcriptional Activation:** Once inside the nucleus, Yap forms a transcriptional complex with TEAD (TEA domain transcription factor). This complex drives the expression of genes involved in liver regeneration, including HB-EGF.

### **HB-EGF: A Key Mediator**

HB-EGF is a growth factor that plays a dual role as both a signaling molecule and a bridge between endothelial cells and hepatocytes during liver regeneration:

1. **Induction by Mechanocrine Signaling:** The mechanical stretch of LSECs induces HB-EGF expression through the Yap-TEAD pathway.

2. **Timing:** HB-EGF levels begin to rise within 3 hours after PHx and peak at around 48 hours, coinciding with the peak of hepatocyte proliferation.

3. **Action on Hepatocytes:** HB-EGF secreted by LSECs binds to EGFR (epidermal growth factor receptor) on hepatocytes, promoting their proliferation and contributing to the restoration of liver mass.

### **Mechanistic Cascade**

The sequence of events following PHx and the role of mechanocrine signaling can be summarized as follows:

1. **Mechanical Trigger:** Increased sinusoidal flow and shear stress activate integrin β1 on LSECs.

2. **Actin Polymerization:** Integrin β1 signaling induces actin polymerization, opening nuclear pores.

3. **Yap Activation:** Yap migrates to the nucleus and binds TEAD to initiate transcriptional programs.

4. **HB-EGF Expression:** Yap-TEAD drives the upregulation of HB-EGF in LSECs.

5. **Endothelial-Hepatocyte Communication:** HB-EGF acts on hepatocytes via EGFR, promoting their proliferation.

### **Cooperation with Other Signals**

While mechanocrine signaling is crucial, liver regeneration also depends on classical ligand-receptor signaling pathways:

1. **EGFR and MET Activation:** Growth factors like EGF, TGFα, HB-EGF, and HGF activate receptor tyrosine kinases (EGFR and MET), driving hepatocyte proliferation.

2. **Extracellular Matrix Remodeling:** Early activation of urokinase releases active HGF from the extracellular matrix, further enhancing mitogenic signaling alongside HB-EGF.

### **Significance of Yap and Mechanocrine Signaling**

1. **Essential Role:** Inhibition of Yap, either genetically or pharmacologically, suppresses HB-EGF expression, confirming that Yap is indispensable for this mechanocrine pathway.

2. **Flow-Dependent Regulation:** The amount of HB-EGF produced by LSECs is directly proportional to the mechanical stress they experience, emphasizing the importance of blood flow in driving liver regeneration.

3. **New Paradigm:** Mechanocrine signaling via Yap and HB-EGF represents a novel and underappreciated mechanism in liver regeneration biology. It complements classical signaling pathways, highlighting the liver's ability to integrate mechanical and biochemical cues.

### **Parallel Mechanosensitive Pathways in Hepatocytes**

Similar mechanosensitive mechanisms are likely active in hepatocytes themselves:

1. **Integrin β1 and Yap Activation:** Mechanical stress may also activate integrin β1 and Yap in hepatocytes, promoting their proliferation.

2. **Early Activation Events:** Rapid membrane potential changes, β-catenin, and Notch-1 activation in hepatocytes suggest an immediate mechanochemical response following PHx.

### **Conclusion**

Mechanocrine signaling, mediated by Yap and HB-EGF, is a crucial component of liver regeneration. It highlights the liver's unique ability to use mechanical forces, alongside classical ligand-receptor interactions, to coordinate the complex process of tissue regrowth. This paradigm emphasizes the integration of mechanical and biochemical signals in organ regeneration, providing new insights into liver biology and potential therapeutic targets for liver injuries or diseases.

Related Q&A

ARID1A Loss Drives ICC Development: Hepatology | June 2026

Introduction: Intrahepatic cholangiocarcinoma (ICC) is an aggressive primary liver cancer with poor prognosis and limited treatment options. While ICC has traditionally been considered a malignancy of biliary epithelial cells, increasing evidence suggests that hepatocytes can...

Blocking Succinate–GPR91 Signaling in MASH: Hepatology | April 2026

Introduction: Liver fibrosis is the key determinant of long-term outcomes in metabolic dysfunction-associated steatohepatitis (MASH). Activated hepatic stellate cells (HSCs) drive fibrogenesis, but effective antifibrotic therapies remain unavailable. This study investigated whether blocking the succinate–GPR91...

THRSP–MIF Signaling Drives MASH Progression: Hepatology | April 2026

Introduction: The progression from metabolic dysfunction-associated fatty liver (MAFL) to metabolic dysfunction-associated steatohepatitis (MASH) is driven by complex interactions between hepatocytes and immune cells. This study identifies a novel spatial mechanism in the periportal (PP)...

Butyrate and Butyrate-Producing Bacteria in CKM: Antioxidants | July 2026

Introduction: Cardiovascular–Kidney–Metabolic (CKM) syndrome recognizes the close interaction between obesity, type 2 diabetes, chronic kidney disease, and cardiovascular disease. This review highlights the emerging role of the gut microbiome, particularly butyrate-producing bacteria, as a central...

CK7, CK20, and CDX2 Refine Prognosis in Small Intestinal Adenocarcinoma: Annals of Oncology | 2026

• Small intestinal adenocarcinoma (SIA) is a rare gastrointestinal cancer with limited disease-specific prognostic biomarkers and generally poor outcomes. • This nationwide Dutch population-based study evaluated whether three routinely available immunohistochemical markers—CK7, CK20, and CDX2—have...

Fatty Liver Drives Hyperglycemia Through Liver–Gut Signaling : Cell Metab | Jun 2026

Introduction: Metabolic dysfunction–associated steatotic liver disease (MASLD) is closely linked to insulin resistance and type 2 diabetes, with the liver traditionally viewed as a key regulator of blood glucose through hepatic glucose production. However, emerging...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer